Management of in-stent restenosis in a patient with a drug eluting stent on hemodialysis awaiting renal transplantation.
This brief report describes the dilemma of managing significant in-stent restenosis in a diabetic patient of end stage renal disease on regular hemodialysis awaiting renal transplantation within a paclitaxel eluting stent in his proximal left anterior descending artery with moderately impaired left ventricle systolic dysfunction. In view of the imminent renal transplantation procedure the patient underwent percutaneous coronary intervention with a cobalt chromium bare metal stent and was subsequently taken up for successful renal transplantation after 6 weeks with temporary discontinuation of antiplatelet therapy.
Natarajan
Deepak
D
Department of Cardiology, Indraprastha Apollo Hospitals, New Delhi, India.
Sarin
Ashok
A
Upadhyaya
Sachin
S
D015906:Angioplasty, Balloon, Coronary; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D002637:Chest Pain; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000628:therapy*; D054855:Drug-Eluting Stents; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy*; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000627:therapeutic use; D006435:Renal Dialysis; D018487:Ventricular Dysfunction, Left / Q000628:therapy
D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel